v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Voting
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Retained Earnings
Beginning balance, common stock (in shares) at Mar. 31, 2021   124,197,974        
Beginning balance at Mar. 31, 2021 $ 2,005,779 $ 124 $ 2,955,400 $ (1,940) $ (1,322,496) $ 374,691
Beginning balance, treasury stock (in shares) at Mar. 31, 2021         50,446,359  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 44,280         44,280
Unrealized net investment gains (5)     (5)    
Unrealized net gain (loss) on derivative financial instruments 99     99    
Cumulative translation adjustments 51     51    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,688,026        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 41,389   41,389      
Issuance of common stock under employee stock purchase plan (in shares)   251,308        
Issuance of common stock under employee stock purchase plan 6,890   6,890      
Repurchase of treasury stock (in shares)         1,862,403  
Repurchase of treasury stock (50,898)       $ (50,898)  
Ending balance, common stock (in shares) at Dec. 31, 2021   126,137,308        
Ending balance at Dec. 31, 2021 2,047,587 $ 126 3,003,679 (1,795) $ (1,373,394) 418,971
Ending balance, treasury stock (in shares) at Dec. 31, 2021         52,308,762  
Beginning balance, common stock (in shares) at Sep. 30, 2021   126,108,858        
Beginning balance at Sep. 30, 2021 1,999,004 $ 126 2,991,704 (1,931) $ (1,362,141) 371,246
Beginning balance, treasury stock (in shares) at Sep. 30, 2021         51,891,197  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 47,725         47,725
Unrealized net investment gains 0          
Unrealized net gain (loss) on derivative financial instruments 52     52    
Cumulative translation adjustments 84     84    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   28,450        
Issuance of common stock pursuant to vesting of restricted stock units 0 $ 0        
Stock-based compensation expense for restricted stock units granted to employees 11,975   11,975      
Repurchase of treasury stock (in shares)         417,565  
Repurchase of treasury stock (11,253)       $ (11,253)  
Ending balance, common stock (in shares) at Dec. 31, 2021   126,137,308        
Ending balance at Dec. 31, 2021 $ 2,047,587 $ 126 3,003,679 (1,795) $ (1,373,394) 418,971
Ending balance, treasury stock (in shares) at Dec. 31, 2021         52,308,762  
Beginning balance, common stock (in shares) at Mar. 31, 2022 74,102,293 126,425,383        
Beginning balance at Mar. 31, 2022 $ 2,060,395 $ 126 3,023,403 141 $ (1,373,840) 410,565
Beginning balance, treasury stock (in shares) at Mar. 31, 2022 52,323,090       52,323,090  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 62,869         62,869
Unrealized net investment gains 14     14    
Unrealized net gain (loss) on derivative financial instruments (61)     (61)    
Cumulative translation adjustments (447)     (447)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,758,002        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 45,068   45,068      
Issuance of common stock under employee stock purchase plan (in shares)   206,029        
Issuance of common stock under employee stock purchase plan 6,539   6,539      
Repurchase of treasury stock (in shares)         5,104,980  
Repurchase of treasury stock $ (169,226)   2,856   $ (172,082)  
Ending balance, common stock (in shares) at Dec. 31, 2022 70,961,344 128,389,414        
Ending balance at Dec. 31, 2022 $ 2,005,153 $ 128 3,077,866 (353) $ (1,545,922) 473,434
Ending balance, treasury stock (in shares) at Dec. 31, 2022 57,428,070       57,428,070  
Beginning balance, common stock (in shares) at Sep. 30, 2022   128,373,156        
Beginning balance at Sep. 30, 2022 $ 1,937,646 $ 128 3,015,644 (1,056) $ (1,497,886) 420,816
Beginning balance, treasury stock (in shares) at Sep. 30, 2022         56,129,506  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 52,618         52,618
Unrealized net investment gains 25     25    
Unrealized net gain (loss) on derivative financial instruments 564     564    
Cumulative translation adjustments 114     114    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   16,258        
Issuance of common stock pursuant to vesting of restricted stock units 0          
Stock-based compensation expense for restricted stock units granted to employees 14,366   14,366      
Repurchase of treasury stock (in shares)         1,298,564  
Repurchase of treasury stock $ (180)   47,856   $ (48,036)  
Ending balance, common stock (in shares) at Dec. 31, 2022 70,961,344 128,389,414        
Ending balance at Dec. 31, 2022 $ 2,005,153 $ 128 $ 3,077,866 $ (353) $ (1,545,922) $ 473,434
Ending balance, treasury stock (in shares) at Dec. 31, 2022 57,428,070       57,428,070